nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—Antrafenine—PTGS2—adrenal gland cancer	0.0145	1	CrCbGaD
Flavoxate—PDE7B—adrenal gland—adrenal gland cancer	0.00971	0.114	CbGeAlD
Flavoxate—PDE8A—adrenal cortex—adrenal gland cancer	0.00964	0.113	CbGeAlD
Flavoxate—PDE8B—gonad—adrenal gland cancer	0.00887	0.104	CbGeAlD
Flavoxate—PDE8A—cardiac atrium—adrenal gland cancer	0.00797	0.0935	CbGeAlD
Flavoxate—PDE8A—pituitary gland—adrenal gland cancer	0.00779	0.0914	CbGeAlD
Flavoxate—PDE8B—adrenal gland—adrenal gland cancer	0.00773	0.0907	CbGeAlD
Flavoxate—PDE8A—adrenal gland—adrenal gland cancer	0.00696	0.0816	CbGeAlD
Flavoxate—PDE4D—adrenal gland—adrenal gland cancer	0.0063	0.074	CbGeAlD
Flavoxate—PDE4A—adrenal gland—adrenal gland cancer	0.00558	0.0655	CbGeAlD
Flavoxate—PDE4B—gonad—adrenal gland cancer	0.00382	0.0448	CbGeAlD
Flavoxate—PDE4B—cardiac atrium—adrenal gland cancer	0.00381	0.0447	CbGeAlD
Flavoxate—PDE4B—pituitary gland—adrenal gland cancer	0.00372	0.0437	CbGeAlD
Flavoxate—PDE4B—adrenal gland—adrenal gland cancer	0.00333	0.039	CbGeAlD
Flavoxate—PDE4B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00127	0.00141	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00126	0.0014	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00126	0.0014	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00125	0.00139	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00124	0.00138	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0012	0.00134	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—POMC—adrenal gland cancer	0.0012	0.00133	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—POMC—adrenal gland cancer	0.0012	0.00133	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00118	0.00131	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—PRKACA—adrenal gland cancer	0.00118	0.00131	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—PRKACA—adrenal gland cancer	0.00118	0.00131	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00115	0.00128	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00111	0.00124	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—POMC—adrenal gland cancer	0.00109	0.00121	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—POMC—adrenal gland cancer	0.00109	0.00121	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00108	0.0012	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00108	0.0012	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—POMC—adrenal gland cancer	0.00107	0.00119	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00107	0.00118	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PRKACA—adrenal gland cancer	0.00105	0.00117	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00102	0.00113	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00101	0.00112	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00101	0.00112	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CDC42—adrenal gland cancer	0.000999	0.00111	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CDC42—adrenal gland cancer	0.000999	0.00111	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—GNRH1—adrenal gland cancer	0.000994	0.0011	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000993	0.0011	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000976	0.00108	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—POMC—adrenal gland cancer	0.00097	0.00108	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IGF2—adrenal gland cancer	0.000963	0.00107	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IGF2—adrenal gland cancer	0.000963	0.00107	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.000962	0.00107	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000961	0.00107	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—GNAS—adrenal gland cancer	0.000954	0.00106	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—GNAS—adrenal gland cancer	0.000954	0.00106	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00095	0.00106	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000937	0.00104	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000931	0.00103	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000931	0.00103	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000925	0.00103	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000913	0.00101	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—CDC42—adrenal gland cancer	0.000913	0.00101	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000913	0.00101	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SPRY2—adrenal gland cancer	0.000909	0.00101	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—POMC—adrenal gland cancer	0.000901	0.001	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000892	0.000991	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CDC42—adrenal gland cancer	0.00089	0.000989	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TSHR—adrenal gland cancer	0.000886	0.000984	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000885	0.000983	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000875	0.000972	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000874	0.000971	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000872	0.000969	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GNRH1—adrenal gland cancer	0.000865	0.000961	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IGF2—adrenal gland cancer	0.000858	0.000953	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—GNAS—adrenal gland cancer	0.000851	0.000945	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000836	0.000929	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000833	0.000926	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MEN1—adrenal gland cancer	0.000833	0.000925	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IGF1R—adrenal gland cancer	0.00083	0.000922	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CDC42—adrenal gland cancer	0.000828	0.000919	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000825	0.000917	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000824	0.000915	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TERT—adrenal gland cancer	0.000801	0.00089	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TERT—adrenal gland cancer	0.000801	0.00089	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IGF2—adrenal gland cancer	0.000798	0.000886	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000796	0.000884	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—CDC42—adrenal gland cancer	0.000795	0.000883	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SPRY2—adrenal gland cancer	0.000792	0.000879	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—GNAS—adrenal gland cancer	0.000791	0.000879	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TSHR—adrenal gland cancer	0.000771	0.000857	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000771	0.000857	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000771	0.000856	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000762	0.000847	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—GNAS—adrenal gland cancer	0.00076	0.000844	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000757	0.00084	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000753	0.000837	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000737	0.000818	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TSHR—adrenal gland cancer	0.000734	0.000816	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MEN1—adrenal gland cancer	0.000725	0.000806	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000723	0.000803	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TERT—adrenal gland cancer	0.000714	0.000793	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CDC42—adrenal gland cancer	0.0007	0.000778	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000697	0.000774	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—BAD—adrenal gland cancer	0.000697	0.000774	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—BAD—adrenal gland cancer	0.000697	0.000774	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MEN1—adrenal gland cancer	0.00069	0.000767	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TSHR—adrenal gland cancer	0.000679	0.000755	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000669	0.000743	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TERT—adrenal gland cancer	0.000664	0.000738	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000647	0.000719	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—POMC—adrenal gland cancer	0.000643	0.000714	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—POMC—adrenal gland cancer	0.000643	0.000714	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MEN1—adrenal gland cancer	0.000639	0.000709	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000636	0.000706	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—BRAF—adrenal gland cancer	0.000635	0.000705	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—BRAF—adrenal gland cancer	0.000635	0.000705	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—BAD—adrenal gland cancer	0.000621	0.00069	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000615	0.000683	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000615	0.000683	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000615	0.000683	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00061	0.000678	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000609	0.000676	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000602	0.000669	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—POMC—adrenal gland cancer	0.000587	0.000653	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—BAD—adrenal gland cancer	0.000578	0.000642	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—POMC—adrenal gland cancer	0.000573	0.000636	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—BRAF—adrenal gland cancer	0.000566	0.000628	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—POMC—adrenal gland cancer	0.000563	0.000626	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00056	0.000622	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000554	0.000616	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PRKACA—adrenal gland cancer	0.000554	0.000615	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000553	0.000614	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000548	0.000609	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000547	0.000608	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000546	0.000607	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000544	0.000604	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CDC42—adrenal gland cancer	0.000539	0.000599	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000539	0.000599	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000537	0.000596	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000536	0.000595	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—POMC—adrenal gland cancer	0.000533	0.000592	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000527	0.000585	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—BRAF—adrenal gland cancer	0.000526	0.000584	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IGF2—adrenal gland cancer	0.00052	0.000578	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—GNAS—adrenal gland cancer	0.000515	0.000573	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—POMC—adrenal gland cancer	0.000511	0.000568	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—EGFR—adrenal gland cancer	0.00051	0.000566	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000508	0.000564	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000507	0.000563	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000503	0.000558	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000501	0.000557	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.0005	0.000556	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000496	0.000551	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000495	0.00055	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000494	0.000549	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000489	0.000543	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000488	0.000542	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000488	0.000542	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—POMC—adrenal gland cancer	0.000487	0.000541	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000478	0.000531	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000471	0.000524	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CDC42—adrenal gland cancer	0.00047	0.000522	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000459	0.000509	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000459	0.000509	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IGF2—adrenal gland cancer	0.000453	0.000503	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—POMC—adrenal gland cancer	0.00045	0.0005	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GNAS—adrenal gland cancer	0.000449	0.000498	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CDC42—adrenal gland cancer	0.000447	0.000496	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000438	0.000486	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TERT—adrenal gland cancer	0.000433	0.000481	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IGF2—adrenal gland cancer	0.000431	0.000479	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GNAS—adrenal gland cancer	0.000427	0.000474	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000417	0.000463	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CDC42—adrenal gland cancer	0.000414	0.000459	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000409	0.000454	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF2—adrenal gland cancer	0.000399	0.000443	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GNAS—adrenal gland cancer	0.000395	0.000439	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000385	0.000428	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00038	0.000422	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000378	0.00042	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.000377	0.000419	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TERT—adrenal gland cancer	0.000377	0.000418	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—BAD—adrenal gland cancer	0.000376	0.000418	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.000372	0.000413	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EGFR—adrenal gland cancer	0.000363	0.000404	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EGFR—adrenal gland cancer	0.000363	0.000404	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TERT—adrenal gland cancer	0.000359	0.000398	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000354	0.000394	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00035	0.000389	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—POMC—adrenal gland cancer	0.000347	0.000385	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—BRAF—adrenal gland cancer	0.000343	0.000381	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000335	0.000372	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000332	0.000369	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TERT—adrenal gland cancer	0.000332	0.000369	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000331	0.000368	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—BAD—adrenal gland cancer	0.000328	0.000364	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000327	0.000364	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000327	0.000363	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EGFR—adrenal gland cancer	0.000324	0.00036	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000323	0.000359	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000316	0.000351	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000312	0.000347	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—BAD—adrenal gland cancer	0.000312	0.000346	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—adrenal gland cancer	0.000305	0.000339	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—adrenal gland cancer	0.000305	0.000339	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—POMC—adrenal gland cancer	0.000302	0.000336	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EGFR—adrenal gland cancer	0.000301	0.000334	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000301	0.000334	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000299	0.000333	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—BRAF—adrenal gland cancer	0.000298	0.000331	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000297	0.00033	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000296	0.000328	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.000292	0.000324	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000289	0.000321	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—BAD—adrenal gland cancer	0.000289	0.000321	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000288	0.00032	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—POMC—adrenal gland cancer	0.000288	0.000319	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000287	0.000319	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—BRAF—adrenal gland cancer	0.000284	0.000315	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000284	0.000315	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000275	0.000306	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000274	0.000305	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—adrenal gland cancer	0.000272	0.000302	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000271	0.000301	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—POMC—adrenal gland cancer	0.000266	0.000296	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—BRAF—adrenal gland cancer	0.000263	0.000292	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000255	0.000283	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—adrenal gland cancer	0.000253	0.000281	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000248	0.000275	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000216	0.000239	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000213	0.000237	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.00021	0.000234	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000209	0.000233	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000207	0.00023	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000205	0.000228	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—adrenal gland cancer	0.000196	0.000218	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000193	0.000215	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000191	0.000212	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00019	0.000211	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000178	0.000197	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000175	0.000195	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000171	0.00019	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—adrenal gland cancer	0.000171	0.00019	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.00017	0.000189	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000169	0.000188	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000168	0.000186	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000166	0.000184	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—adrenal gland cancer	0.000165	0.000183	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000163	0.000182	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—adrenal gland cancer	0.000163	0.000181	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—adrenal gland cancer	0.00015	0.000167	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—adrenal gland cancer	0.000143	0.000159	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000142	0.000158	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000141	0.000156	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—adrenal gland cancer	0.000137	0.000152	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—adrenal gland cancer	0.000126	0.00014	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000124	0.000138	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000122	0.000136	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000114	0.000127	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000113	0.000125	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000113	0.000125	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000111	0.000124	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000109	0.000121	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000108	0.00012	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	8.16e-05	9.06e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	8.05e-05	8.94e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	6.46e-05	7.18e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	6.38e-05	7.08e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	5.42e-05	6.03e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	5.36e-05	5.95e-05	CbGpPWpGaD
